CYCLE PHARMACEUTICALS LTD
Get an alert when CYCLE PHARMACEUTICALS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£18M
USD 24,315,000
-64.4% lowest in 3 filed years
Net assets
£63M
USD 83,691,000
+37.4% highest in 3 filed years
Employees
72
+33.3% highest in 3 filed years
Profit before tax
£41M
USD 54,205,000
+26.6% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £75,812,996 | £99,934,122 | £132,802,815 | +32.9% | |
| Operating profit | £13,348,555 | £30,732,894 | £39,332,984 | +28% | |
| Profit before tax | £13,403,953 | £32,042,222 | £40,578,679 | +26.6% | |
| Net profit | £13,842,641 | £28,530,469 | £31,993,562 | +12.1% | |
| Cash | £19,351,699 | £51,081,000 | £18,202,575 | -64.4% | |
| Total assets less current liabilities | £38,215,302 | £45,649,049 | — | — | |
| Net assets | £38,007,935 | £45,584,668 | £62,652,343 | +37.4% | |
| Equity | £38,007,935 | £45,584,668 | £62,652,343 | +37.4% | |
| Average employees | 42 | 54 | 72 | +33.3% | |
| Wages | £3,674,951 | £5,457,404 | £7,371,613 | +35.1% | |
| Directors' remuneration | £1,363,977 | £1,813,894 | £2,004,791 | +10.5% |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 17.6% | 30.8% | 29.6% | |
| Net margin | 18.3% | 28.5% | 24.1% | |
| Return on capital employed | 34.9% | 67.3% | — | |
| Gearing (liabilities / total assets) | — | 46.9% | 47.7% | |
| Current ratio | 2.18x | 1.88x | 1.21x | |
| Interest cover | 62.13x | 81.94x | 35.29x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors expect that the company can continue as a going concern for a period greater than twelve months from the date of approval of these financial statements, and the financial statements have been prepared on a going concern basis”
Significant events
- “On 3 February 2026, AT2B Inc, which is an indirect subsidiary of Cycle Pharmaceuticals Ltd, merged with Applied Therapeutics Inc”
- “On 26 February 2026, Cycle Pharmaceuticals Ltd declared an interim dividend of $6,000k to the parent company, Cycle Group Holdings Limited”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HARRISON, James Alexander | Director | 2021-12-21 | Feb 1974 | British |
| KENNEDY, Duncan | Director | 2025-01-15 | May 1975 | British |
| REINER, Andrea Curti | Director | 2025-11-13 | Mar 1974 | British,American |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BENEDETTI, Antonio | Director | 2016-01-25 | 2021-12-21 |
| GOWING, Sarah Jean | Director | 2021-09-29 | 2025-11-13 |
| HARRISON, James Alexander | Director | 2012-02-02 | 2021-09-29 |
| LEFKOWITZ, Allen | Director | 2013-11-01 | 2021-03-31 |
| MCCUE, Stephen Gerard | Director | 2021-09-29 | 2024-10-03 |
| MOODY, Denise Mary | Director | 2021-09-29 | 2022-06-09 |
| MOORE, Duncan Charles Mcnaught, Dr | Director | 2014-06-27 | 2021-09-29 |
| REASON, Ross George | Director | 2020-06-11 | 2021-09-29 |
| ROBINSON, William John | Director | 2013-11-01 | 2021-09-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Cycle Group Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2020-09-29 | Active |
| Mr James Alexander Harrison | Individual | Shares 50–75% | 2016-04-06 | Ceased 2020-09-29 |
Filing timeline
Last 20 of 85 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-06 | AA | accounts | Accounts with accounts type full | |
| 2026-01-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-13 | AA | accounts | Accounts with accounts type full | |
| 2025-08-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-05-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-08 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-08 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-08 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-04-04 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-02-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-27 | AA | accounts | Accounts with accounts type full | |
| 2024-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-08 | AA | accounts | Accounts with accounts type full | |
| 2023-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-20 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-25 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.